Vimarsana
Biggest News Aggregation in the World

Ouest Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ouest Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ouest Ventures Today - Breaking & Trending Today

Following the Announcement of Its Proposed Merger With Erytech, Pherecydes Pharma Completes a €1.5 Million Capital Increase Reserved to Its Historical Shareholders - Vimarsana News

Following the Announcement of Its Proposed Merger With Erytech, Pherecydes Pharma Completes a €1.5 Million Capital Increase Reserved to Its Historical Shareholders

Published: February 17, 2023

This capital increase, fully subscribed by Auriga IV Bioseeds, Ouest Ventures III and the pool of shareholders represented by Guy Rigaud, historical shareholders of Pherecydes Pharma, is part of

Source: finanznachrichten.de
Related Topics:
United StatesFrance GeneralUnited KingdomSouth AfricaErytech PharmaDennis RiedlPherecydes PharmaArthur RouillDusan Oresansky Nicolas FossiezEuropean ParliamentCompany BoardFinancial ServicesBoard Of Directors The CompanyOuest VenturesGuy RigaudElaia PartnersExtraordinary General MeetingFrench Commercial CodeCapital IncreaseNew SharesEuronext GrowthFinancial ReportGeneral MeetingMember StatesEuropean Economic Area
Pherecydes Pharma: ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies - Vimarsana News

Pherecydes Pharma: ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies

Published: February 15, 2023

Conference call and webcast in English on February 16, 2023 at 8:30am EST 02:30pm CET and in French on the same day at 12pm EST 6pm CET Strategic combination would build on complementary expertise

Source: finanznachrichten.de
Related Topics:
United StatesFrance GeneralSouth AfricaGil BeyenDennis RiedlDusan Oresansky Nicolas FossiezMathilde Bohin Louis Victor DelouvrierNicolas MerigeauDidier HochEnregistrement UniverselPharma BioPherecydes PharmaArthur RouillJean Paul KressEric SoyerLyon Commercial CourtErytech Pharma IncExchange CommissionStrategic CommitteeEconomic CommitteeNasdaq EuronextEuronext GrowthChief Executive OfficerProposed MergerAuriga Partners